Evaluate long-term performance of the 4195 LV Lead. This evaluation is based on the number of lead-related complications occuring during the study compared to the number of leads enrolled in the study. The leads will be followed for 5 years after implant. This study is required by FDA as a condition of approval of the Model 4195 LV Lead and is integrated within Medtronic's post-market surveillance platform.
Model 4195 LV lead complication-free survivability will be summarized.
Study Type
OBSERVATIONAL
Enrollment
1,322
Lead-related complication rate.
Time frame: Implant to 5 years post-implant.
Types of Model 4195 lead-related events
Time frame: 5 years post implant
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Anchorage, Alaska, United States
Unnamed facility
Phoenix, Arizona, United States
Unnamed facility
Scottsdale, Arizona, United States
Unnamed facility
Chula Vista, California, United States
Unnamed facility
Redding, California, United States
Unnamed facility
Salinas, California, United States
Unnamed facility
Stanford, California, United States
Unnamed facility
Torrance, California, United States
Unnamed facility
Colorado Springs, Colorado, United States
Unnamed facility
New Haven, Connecticut, United States
...and 57 more locations